Skip to content

mNGS for Detection of Pathogens for Pulmonary Infection

Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing for Pulmonary Infection in Clinical Settings

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03798925
Enrollment
100
Registered
2019-01-10
Start date
2018-08-19
Completion date
2019-02-28
Last updated
2019-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Infection

Brief summary

Pulmonary infections remain the leading causes of morbidity and mortality among patients worldwide. Pathogen identification is crucial yet difficult for the majority of the cases. Metagenomic Next-generation Sequencing provides a potential technology for rapid and untargeted pathogen detection for pulmonary infection. The study is designed observationally to investigate if mNGS is superior to traditional paradigm of serial tests in the aspect of diagnostic performance. Patients whose primary diagnosis is pulmonary infetion and bronchoalveolar lavage fluid can be obtained will be enrolled. Both mNGS and traditional paradigm of serial tests wil be performed.

Interventions

OTHERNone Intervention

It is observational study

Sponsors

Sir Run Run Shaw Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Pulmonary infection as the primary diagnosis * Bronchoalveolar lavage fluid can be obtained

Exclusion criteria

* when the primary diagnosis is tumor or connective tissue diseases * microbiological diagnosis is confirmed before bronchoalveolar lavage * not enough bronchoalveolar lavage fluid for mNGS

Design outcomes

Primary

MeasureTime frameDescription
microbiological diagnosis (pathogen of pulmonary infection)through study completion, up to 6 monthsthe final microbiological diagnosis (pathogen of pulmonary infection) after using of every detection method and combined with clinical manifestations.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026